Peter Gilbert and SCHARP researchers, HVTN Laboratory Program, part of worldwide effort to understand trial outcome, influence future HIV vaccine studies
Science magazine selected HIV prevention trial for its top honor of 2011; study showed early antiretroviral therapy reduced heterosexual HIV transmission by 96 percent